Establishment of immunotherapy with chemotherapy in osteosarcomas
| Project/Area Number |
22591671
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Orthopaedic surgery
|
|---|
| Research Institution | Hyogo Medical University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
FUKUNAGA Satoru 兵庫医科大学, 医学部, 助教 (40441290)
TERADA Nobuyuki 兵庫医科大学, 医学部, 教授 (50150339)
|
|---|
| Project Period (FY) |
2010 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2012: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2011: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2010: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Keywords | 骨肉腫 / 肺転移 / 化学療法 / 免疫療法 / 悪性骨腫瘍 / サイトカイン / 骨腫瘍 / インターロイキン |
|---|
| Research Abstract |
We investigated the effects of valproic acid (VPA) (a histone deacetylase inhibitor) in combination with hydralazine (Hy) (a DNA methylation inhibitor) to enhance the therapeutic effects of immunotherapy of interleukin-18 in osteosarcomas.
|
Report
(4 results)
Research Products
(29 results)
-
-
-
[Journal Article] Downregulation of matrix metalloproteinase-9 mRNA by valproic acid plays a role in inhibiting the shedding of MHC class I-related molecules A and B on the surface of human osteosarcoma cells.2012
Author(s)
Yamanegi K, Yamane J, Kobayashi K, Ohyama H, Nakasho K, Yamada N, Hata M, Fukunaga S, Futani H, Okamura H, Terada N.
-
Journal Title
Oncol Rep.
Volume: 28(5)
Issue: 5
Pages: 1585-1590
DOI
Related Report
Peer Reviewed
-
[Journal Article] Valproic acid cooperates with hydralazine to augment the susceptibility of human osteosarcoma2012
Author(s)
Yamanegi K, Yamane J, Kobayashi K, Kato-Kogoe N, Ohyama H, Nakasho K, YamadaN, Hata M, Fukunaga S, Futani H, Okamura H, Terada N.
-
Journal Title
cells to Fas- and NK cell-mediated cell death.Int J Oncol.
Volume: 41(1)
Pages: 83-91
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
[Journal Article] Terada N. Sodium valproate, a histone deacetylase inhibitor, augments the expression of cell-surface NKG2D ligands, MICA/B, without increasing their soluble forms to enhance susceptibility of human osteosarcoma cells to NK cell-mediated cytotoxicity.2010
Author(s)
Yamanegi K, Yamane J, Kobayashi K, Kato-Kogoe N, Ohyama H, Nakasho K, Yamada N, Hata M, Nishioka T, Fukunaga S, Futani H, Okamura H
-
Journal Title
Oncol Rep
Volume: 24(6)
Pages: 1621-1627
URL
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
